LEGACY, THE SPERM TESTING AND FREEZING COMPANY, RELEASES NEW AT-HOME SAMPLE COLLECTION KIT
NEW YORK, July 22, 2024 /PRNewswire/ -- Legacy, North America's #1 digital fertility clinic for men, has released a new...
NEW YORK, July 22, 2024 /PRNewswire/ -- Legacy, North America's #1 digital fertility clinic for men, has released a new...
Company Now Servicing Over 9 Million Veterans NEW YORK, July 19, 2024 /PRNewswire/ -- Legacy, North America's #1 digital fertility...
- Independent committee confirms FALCON study is powered for potential success with both alternative endpoints passing futility- -Committee confirms strong...
First-of-its-kind experience celebrates the launch of 30+ new Performance Traits that show how DNA influences athletic ability LEHI, Utah , July...
STONY BROOK, NY / ACCESSWIRE / July 18, 2024 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA), a leader in...
BALTIMORE, Md. and BASKING RIDGE, N.J., July 18, 2024 (GLOBE NEWSWIRE) -- Haystack Oncology, a Quest Diagnostics (NYSE: DGX) company,...
WARMINSTER, Pa., July 18, 2024 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company leveraging its extensive...
NEW YORK, July 17, 2024 /PRNewswire/ -- The global cancer registry software market size is estimated to grow by USD...
PLANO, Texas, July 17, 2024 /PRNewswire/ -- staffdna®, creator of The Digital Marketplace for Healthcare Careers, proudly announces the grand...
The total number of Hyperfine AI-powered marketing authorizations places the company in a leading position on recently published FDA list.GUILFORD,...
The total number of Hyperfine AI-powered marketing authorizations places the company in a leading position on recently published FDA list.GUILFORD,...
Media Release Study expected to enrol first participants during Q3 CY2024 SYDNEY, AUSTRALIA, July 17, 2024 (GLOBE NEWSWIRE) -- Immutep...
– 43% of Participants Showed Improvement on the UMSARS Activities of Daily Living Scale – – 29% of Participants had...
SUNNYVALE, Calif., July 17, 2024 (GLOBE NEWSWIRE) -- BioCardia, Inc. , a company focused on cellular and cell-derived therapeutics for the...
- 6E10 combined with local prophylaxis selected for Phase 3 pivotal trials, with a favorable safety profile and potential best-in-class...
CHENGDU, China, July 16, 2024 /PRNewswire/ -- "Evolving DNA-Encoded Library Technology and Its Application for Innovative Drug Discovery" webinar will be...
Syngenta will leverage Ginkgo's Ag Biologicals capabilities to optimize secondary metabolite production for a pioneering biological solution BASEL, Switzerland and...
LOS ANGELES, July 16, 2024 (GLOBE NEWSWIRE) -- Trethera Corporation, a clinical stage biopharmaceutical company committed to developing novel drugs...
MELBOURNE, Australia, July 16, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader...
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, July 11, 2024...